Physiologically‐based pharmacokinetic modeling vs. allometric scaling for the prediction of infliximab pharmacokinetics in pediatric patients
PRV Malik, AN Edginton - CPT: Pharmacometrics & Systems …, 2019 - Wiley Online Library
The comparative performances of physiologically‐based pharmacokinetic (PBPK) modeling
and allometric scaling for predicting the pharmacokinetics (PKs) of large molecules in …
and allometric scaling for predicting the pharmacokinetics (PKs) of large molecules in …
Physiologically‐Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients
PRV Malik, AN Edginton - CPT: Pharmacometrics & Systems …, 2019 - search.proquest.com
The comparative performances of physiologically‐based pharmacokinetic (PBPK) modeling
and allometric scaling for predicting the pharmacokinetics (PKs) of large molecules in …
and allometric scaling for predicting the pharmacokinetics (PKs) of large molecules in …
Physiologically‐Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients.
PRV Malik, AN Edginton - CPT: Pharmacometrics & Systems …, 2019 - search.ebscohost.com
The comparative performances of physiologically‐based pharmacokinetic (PBPK) modeling
and allometric scaling for predicting the pharmacokinetics (PKs) of large molecules in …
and allometric scaling for predicting the pharmacokinetics (PKs) of large molecules in …
[HTML][HTML] Physiologically‐Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients
PRV Malik, AN Edginton - CPT: Pharmacometrics & Systems …, 2019 - ncbi.nlm.nih.gov
The comparative performances of physiologically‐based pharmacokinetic (PBPK) modeling
and allometric scaling for predicting the pharmacokinetics (PKs) of large molecules in …
and allometric scaling for predicting the pharmacokinetics (PKs) of large molecules in …
Physiologically-Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients
PRV Malik, AN Edginton - CPT: pharmacometrics & …, 2019 - pubmed.ncbi.nlm.nih.gov
The comparative performances of physiologically-based pharmacokinetic (PBPK) modeling
and allometric scaling for predicting the pharmacokinetics (PKs) of large molecules in …
and allometric scaling for predicting the pharmacokinetics (PKs) of large molecules in …
[PDF][PDF] Physiologically-Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients
PRV Malik, AN Edginton - researchgate.net
The comparative performances of physiologically-based pharmacokinetic (PBPK) modeling
and allometric scaling for predicting the pharmacokinetics (PKs) of large molecules in …
and allometric scaling for predicting the pharmacokinetics (PKs) of large molecules in …
Physiologically-Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients.
PRV Malik, AN Edginton - CPT: Pharmacometrics & Systems …, 2019 - europepmc.org
The comparative performances of physiologically‐based pharmacokinetic (PBPK) modeling
and allometric scaling for predicting the pharmacokinetics (PKs) of large molecules in …
and allometric scaling for predicting the pharmacokinetics (PKs) of large molecules in …